About Partners Intelligence Log in →
Connecting Israeli Defense Tech to US Needs
Log in

Xmetix

Smart clothing auto-detecting and controlling combat bleeding

Israel
11-50

Latest event found: 1 Feb 2026 · 9 months ago

Vitality Radar

32
Current
6M History
Industry
Updated 25 days ago

Pillar Analysis

Presence
The analyst’s view of digital footprint. Shown for context; not part of the score.
54
Business
Dated funding, customer wins, partnerships and acquisitions made, less down rounds, litigation and regulatory action.
48
Innovation
Dated product launches and regulatory clearances, less products retired.
18
Pulse
Direction: dated events in the last 90 days against the 90 before. 50 is flat.
insufficient evidence
Capacity
Dated hiring, leadership hires, expansion and certifications, less layoffs, departures and closures.
21

Strategic Assessment

Strategic Vector

Xmetix is progressing from an Israeli defense-medical technology startup toward commercialization of its TAK/KAT710 automated tourniquet, with stated ambitions in military, public-safety, civilian, and international markets. Public evidence indicates product development and fundraising activity, but limited independently verifiable evidence of scaled production, procurement, or recurring commercial traction.

Efficiency Ratio

The company appears to be converting a small team and modest visible footprint into a technically differentiated product and regulatory-market development effort, although public evidence is insufficient to establish production efficiency or revenue performance.

Evidence Signals

Funding HIGH IMPACT MEDIUM CONF 1 Feb 2026

A February 2026 regional innovation profile reported that Xmetix was raising a $2 million bridge round to support expansion into United States and European public-safety markets.

View source Israel, United States, European Union
Expansion MEDIUM IMPACT MEDIUM CONF 1 Feb 2026

The company was reported to be pursuing expansion into United States and European public-safety markets alongside its bridge financing effort.

View source United States, European Union

Background · older than 12 months

Product Launch MEDIUM IMPACT MEDIUM CONF 3 Apr 2025

A public company-associated post described the KAT710 as a patented, FDA-approved, fully automatic tourniquet that tightens to optimal pressure after a single-button press.

View source Israel
Award LOW IMPACT MEDIUM CONF 2 Feb 2025

Xmetix was featured in a 2025 article describing Israeli startups developing defense and battlefield technologies, including its automatic tourniquet.

View source Israel
Product Launch MEDIUM IMPACT MEDIUM CONF 19 Dec 2024

Xmetix publicly promoted the TAK710/KAT710 smart tourniquet as an automatic device designed to detect and control bleeding with minimal user intervention.

View source Israel
Partnership LOW IMPACT MEDIUM CONF 1 Jan 2024

The Maayan Fund profile recorded Xmetix as a 2024 partner or portfolio company associated with smart tourniquet technology.

View source Israel
Funding HIGH IMPACT MEDIUM CONF 28 Dec 2023

A December 2023 public post stated that Xmetix had secured significant financial backing led by Fortissimo Capital.

View source Israel

About
Develops smart tactical clothing with sensor mesh technology and the TAK710 automated tourniquet to detect penetrating trauma and autonomously apply hemorrhage control without human intervention.
Relevancy
Reduces preventable combat deaths by providing instant bleeding detection and control. Enables autonomous medical response for extremity injuries, improving survival rates and reducing time to treatment in combat situations.
Tags
#smart-clothing #bleeding-detection #autonomous-medical #combat-survivability #tactical-uniform #tourniquet #sensor-mesh #life-saving

Suggest an edit

Footer

Connecting Israeli Defense Tech to US Needs

Powered by Meschonomy

Terms Privacy Contact